Back

Research Thematic Areas

The research focus of the Department includes but not limited to the following

1. Research thematic areas under the department of Medical Parasitology
  • Evaluating parasitic and vector-borne diseases (VBD), including their transmission dynamics, epidemiology, and control strategies.
  • Advanced diagnostic approaches and evaluation of therapeutic efficacy for neglected tropical diseases (NTDs)
  • Research on Soil-Transmitted Helminths (STH), Schistosomiasis, and Lymphatic Filariasis.
  • Comprehensive evaluation of traditional medicine (TM) approaches using integrated in vitro and in vivo experimental systems
  • Evaluation of point-of-care (PoC) diagnostics, including rapid diagnostic tests (RDTs), assessment of antimalarial drug resistance, and analysis of vector distribution patterns.
  • Advanced investigation of vector ecology, behavior, and transmission dynamics to develop sustainable, evidence-based integrated vector management strategies.
  • Design, development, and evaluation of next-generation vaccines targeting parasitic diseases.
  • Rigorous assessment of novel drugs and interventions to ensure safety, efficacy, and public health impact.
  • Interdisciplinary approaches addressing interconnected human, animal, and environmental health challenges for sustainable outcomes.
  • Red blood Cell and Iron Metabolism Disorders (Anemias, Hemoglobinopathies, RBC Membranopathies, RBC Enzymopathies, Iron homeostasis and regulation, iron overload, hereditary hemochromatosis)
  • Hematopoiesis and Stem Cell Biology (Hematopoiesis and Stem Cell Biology, Hematopoiesis Stem Cell Niche and microenvironment, Cytokine signaling)
  • Hematologic Malignancies (Leukemias, Lymphomas, Multiple myeloma, Molecular pathogenesis and clonal evolution, Targeted therapy and immunotherapy)
  • Genetic and Molecular markers in Hematology (Gene mutations, Epigenetics in blood disorders, Genomic sequencing and precision medicine, Gene therapy)
  • Hemostasis and Thrombosis (Coagulation disorders, platelet disorder, Thrombotic disorders, Anticoagulant therapy and monitoring)
  • Transfusion Medicine and Immunohematology (Blood group systems, Blood safety and screening, Component therapy and rational use, Transfusion reactions and hemovigilance, autoimmune hemolytic anemia, Hemolytic disease of the newborn, Transplant immunology)
  • Infection and Hematology (Hematologic manifestations of infections, Bone marrow suppression, Sepsis-related coagulopathy
  • Immunodiagnostic Techniques in Pathology
  • Emerging Technologies in hematology, transfusion medicine and Histopathology
  • Clinical chemistry research focuses on biomarkers, disease mechanisms, diagnostics, and laboratory innovation across metabolic, organ-specific, and molecular levels.

The main thematic research areas include:

  • Metabolic Disorders and Diabetes
  • Cardiovascular Biomarkers and Risk Assessment
  • Renal Function and Kidney Disease Biomarkers
  • Liver Function and Hepatobiliary Disorders
  • Endocrinology and Hormonal Disorders
  • Cancer Biomarkers and Molecular Diagnostics
  • Inflammation and Immunochemistry
  • Clinical Enzymology and Enzymatic Biomarkers
  • Toxicology and Therapeutic Drug Monitoring
  • Nutrition, Micronutrients, and Metabolic Health
  • Emerging Technologies (Metabolomics and Proteomics in Diagnostics)

Focuses on the isolation, identification, and characterization of infectious agents.

  • Isolation, Identification, and Characterization of Pathogens
    • Application of conventional and advanced diagnostic techniques (culture, serology, and molecular methods) for accurate detection and characterization of bacteria, viruses, fungi, and parasites.
    • Genomic and phenotypic profiling of pathogens to understand virulence, transmission dynamics, and evolution.
  • Hospital-Acquired Infections (HAIs) and Patient Safety
    • Investigation of epidemiology, risk factors, and prevention strategies of HAIs.
    • Major focus on:
      • Respiratory tract infections (including tuberculosis)
      • Urinary tract infections (UTIs)
      • Surgical site infections (SSIs)
      • Blood stream infections (BSIs)
    • Enteric, Food-borne, and Sexually Transmitted Infections
      • Surveillance and characterization of enteric pathogens causing diarrheal diseases.
      • Research on food-borne infections and their public health impact, including outbreak investigation.
      • Study of sexually transmitted infections (STIs), including their epidemiology, diagnostics, and resistance patterns.
    • Antimicrobial Resistance (AMR) using One Health Approach
      • Investigation of molecular mechanisms of AMR in human, animal, and environmental isolates.
      • Integrated One Health surveillance of AMR across human, veterinary, agricultural, and environmental sectors.
      • Development of strategies for AMR containment, including antimicrobial stewardship and policy interventions.
    • Opportunistic and Emerging Fungal Infections
      • Study of opportunistic fungal infections among immunocompromised populations (e.g., HIV/AIDS).
      • Focus on emerging and neglected mycoses, antifungal resistance, and diagnostic challenges.
    • Viral Infections and Emerging Threats
      • Epidemiology, diagnosis, and management challenges of major viral infections, including HIV and viral hepatitis.
      • Surveillance and research on emerging and re-emerging viral diseases.
      • Evaluation of novel diagnostic tools, vaccines, and antiviral strategies.
  • Infectious Diseases and Host Immunity (Immunopathogenesis of major infectious diseases (e.g., HIV, TB, malaria))
  • Molecular Diagnostics and Biomarker Discovery (Development of molecular diagnostic tools (PCR, RT-PCR, NGS)
  • Vaccine Research and Immunotherapy (Design of novel vaccines (e.g., mRNA, DNA, subunit vaccines)
  • Autoimmunity and Immune-Mediated Diseases (Mechanisms of autoimmune diseases (e.g., lupus, rheumatoid arthritis)
  • Cancer Immunology and Molecular Oncology
  • Immunogenetics and Genomics
  • Public Health Immunology and Epidemiology (Seroepidemiological studies (e.g., HIV, STIs, COVID-19)
  • Molecular Mechanisms of Disease (Cell signaling pathways in disease (e.g., NF-κB, MAPK, Epigenetics and gene regulation)
  • Immunology of Skin and Mucosal Systems (Cutaneous immunology, Mucosal immunity, Microbiome, Allergic and inflammatory skin disorders)
  • Advanced Immunological and Molecular Techniques (Flow cytometry and cell sorting, ELISA, Western blot, and immunoassays, Single-cell sequencing and omics technologies and Bioinformatics and computational biology)
  • Evaluation of point-of-care testing (POCT) devices, laboratory quality management systems (LQMS), turnaround time (TAT) optimization, and the integration of digital health information systems.
  • Research on the implementation and impact of international standards like ISO 15189 in local clinical settings.
  • Investigating errors in the pre-analytical (collection/transport), Analytical (testing), and post-analytical (reporting) phases.
  • Evaluating the accuracy and reliability of bedside diagnostic tools compared to central laboratory “gold standards.”
  • Research on the role of digital health and “Big Data” in reducing turnaround times (TAT) and improving diagnostic data management.
  • Studying the environmental impact of laboratory waste and the effectiveness of safety protocols for lab personnel.
  • Studding the barriers to high-quality laboratory services in rural and urban Ethiopian settings.